HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?

In the report the authors analyze the complex problems associated with the formation of regional industrial clusters, initially announced as an innovative structure. The main objectives of the planned is the introduction of the real economy scheme of public-private partnership and in the revival of...

Full description

Bibliographic Details
Main Author: A. N. Tsatsulin
Format: Article
Language:Russian
Published: Real Economy Publishing House 2019-10-01
Series:Стратегии бизнеса
Subjects:
Online Access:https://www.strategybusiness.ru/jour/article/view/568
id doaj-819c0519f9d4423caf3eb247c9083576
record_format Article
spelling doaj-819c0519f9d4423caf3eb247c90835762021-08-02T09:01:15ZrusReal Economy Publishing HouseСтратегии бизнеса2311-71842019-10-0109242910.17747/2311-7184-2019-9-24-29468HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?A. N. Tsatsulin0St Petersburg State University of Economic, St. Petersburg, Russian FederationIn the report the authors analyze the complex problems associated with the formation of regional industrial clusters, initially announced as an innovative structure. The main objectives of the planned is the introduction of the real economy scheme of public-private partnership and in the revival of national medical industry of innovative type, in particular, the sector of pharmaceuticals. Solution of these problems, according to the author, provide a procedure for import of foreign drugs quality Russian pharmaceuticals, which is currently the most important task, which stood in front of society and the state. Expounded material evidence of the relevance of the issues raised by the report. The author examines the pharmaceutical cluster of St. Petersburg, activities, participants, members of these relatively new shape territorial entities, analyzes the innovation activity of a number of existing enterprises producing both generic and original commercial products with innovative features. The latter feature is not always obvious. However, to identify the innovative leaders in the cluster author of the report offers a comparative analysis of multi-dimensional methodology. The report draws conclusions, makes recommendations.https://www.strategybusiness.ru/jour/article/view/568innovative technologiespublic-private partnershipimport substitutiondrugpharmaceutical industrythe purchase of imported drugsmarket of medicinesthe prices of pharmaceutical productsgenericinnovative activity rating
collection DOAJ
language Russian
format Article
sources DOAJ
author A. N. Tsatsulin
spellingShingle A. N. Tsatsulin
HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
Стратегии бизнеса
innovative technologies
public-private partnership
import substitution
drug
pharmaceutical industry
the purchase of imported drugs
market of medicines
the prices of pharmaceutical products
generic
innovative activity rating
author_facet A. N. Tsatsulin
author_sort A. N. Tsatsulin
title HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
title_short HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
title_full HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
title_fullStr HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
title_full_unstemmed HOW TO MEASURE THEINNOVATION OF WHAT IS THE CONDITIONAL INNOVATIVE?
title_sort how to measure theinnovation of what is the conditional innovative?
publisher Real Economy Publishing House
series Стратегии бизнеса
issn 2311-7184
publishDate 2019-10-01
description In the report the authors analyze the complex problems associated with the formation of regional industrial clusters, initially announced as an innovative structure. The main objectives of the planned is the introduction of the real economy scheme of public-private partnership and in the revival of national medical industry of innovative type, in particular, the sector of pharmaceuticals. Solution of these problems, according to the author, provide a procedure for import of foreign drugs quality Russian pharmaceuticals, which is currently the most important task, which stood in front of society and the state. Expounded material evidence of the relevance of the issues raised by the report. The author examines the pharmaceutical cluster of St. Petersburg, activities, participants, members of these relatively new shape territorial entities, analyzes the innovation activity of a number of existing enterprises producing both generic and original commercial products with innovative features. The latter feature is not always obvious. However, to identify the innovative leaders in the cluster author of the report offers a comparative analysis of multi-dimensional methodology. The report draws conclusions, makes recommendations.
topic innovative technologies
public-private partnership
import substitution
drug
pharmaceutical industry
the purchase of imported drugs
market of medicines
the prices of pharmaceutical products
generic
innovative activity rating
url https://www.strategybusiness.ru/jour/article/view/568
work_keys_str_mv AT antsatsulin howtomeasuretheinnovationofwhatistheconditionalinnovative
_version_ 1721236503266328576